The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Glycosphingolipids—Nature, Function, and Pharmacological Modulation
Abstract
The discovery of the glycosphingolipids is generally attributed to Johan L. W. Thudichum, who in 1884 published on the chemical composition of the brain. In his studies he isolated several compounds from ethanolic brain extracts which he coined cerebrosides. He subjected one of these, phrenosin (now known as galactosylceramide), to acid hydrolysis, and this produced three distinct components. One he identified as a fatty acid and another proved to be an isomer of D‐glucose, which is now known as D‐galactose. The third component, with an “alkaloidal nature”, presented “many enigmas” to Thudichum, and therefore he named it sphingosine, after the mythological riddle of the Sphinx. Today, sphingolipids and their glycosidated derivatives are the subjects of intense study aimed at elucidating their role in the structural integrity of the cell membrane, their participation in recognition and signaling events, and in particular their involvement in pathological processes that are at the basis of human disease (for example, sphingolipidoses and diabetes type 2). This Review details some of the recent findings on the biosynthesis, function, and degradation of glycosphingolipids in man, with a focus on the glycosphingolipid glucosylceramide. Special attention is paid to the clinical relevance of compounds directed at interfering with the factors responsible for glycosphingolipid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
New aminocyclitols as modulators of glucosylceramide metabolism
Egido‐Gabás, M., Serrano, P., Casas, J., Llebaria, A., & Delgado, A. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b411473f · Cited by 37
Modulation of cell functions by glycosphingolipid metabolic remodeling in the plasma membrane
Prinetti, A., Chigorno, V., Mauri, L., Loberto, N., & Sonnino, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04714.x · Cited by 37
Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease
Aerts, J. M. F. G., Donker‐Koopman, W. E., KOOT, M., Barranger, J. A., Tager, J. M., & Schram, A. W. (1986) · Clinica Chimica Acta · doi:10.1016/0009-8981(86)90231-7 · Cited by 36
Self-citationSphingolipid management by an orchestra of lipid transfer proteins
Neumann, S., & Gerrit van, M. E. E. R. (2008) · Biological Chemistry · doi:10.1515/bc.2008.154 · Cited by 30
van den Broek, L. A. G. M., Vermaas, D. J., van Boeckel, C. A. A., Rotteveel, F. T. M., Zandberg, P., van Kemenade, F. J., Miedema, F. F., Butters, T. D., Tan, M. C. C. A., & Ploegh, H. L. (1994) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19941131104 · Cited by 28
Shayman, J. A., Abe, A., & Hiraoka, M. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000016739.32089.55 · Cited by 28
Priestman, D. A., van der Spoel, A. C., Butters, T. D., Dwek, R. A., & Platt, F. M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00701.x · Cited by 26
Development of a New Inhibitor of Glucosylceramide Synthase
Jimbo, M., Yamagishi, K., Yamaki, T., Nunomura, K., Kabayama, K., Igarashi, Y., & Inokuchi, J. (2000) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022631 · Cited by 24
Hichem, D. G., & Sandhoff, K. (2008) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.20.277 · Cited by 14
Synthesis and biological evaluation of novel PDMP analogues
Hillaert, U., Boldin‐Adamsky, S., Rozenski, J., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.03.048 · Cited by 12
Kroker, K. (2006) · Canadian Journal of Health History · doi:10.3138/cbmh.23.1.263 · Cited by 8
Cited by
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Metabolic features of chronic fatigue syndrome
Naviaux, R. K., Naviaux, J. C., Li, K., Bright, A. T., Alaynick, W. A., Wang, L., Baxter, A., Nathan, N., Anderson, W., & Gordon, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607571113 · Cited by 391
Van der Lienden, M. J. C., Gaspar, P., Boot, R., Aerts, J. M. F. G., & Van Eijk, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010066 · Cited by 84
Self-citation
Metadata
- Authors
- Wennekes, T., van den Berg, R. J. B. H. N., Boot, R. G., van der Marel, G. A., Overkleeft, H. S., & Aerts, J. M. F. G.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2009-11-04
- Volume
- 48
- Issue
- 47
- Pages
- 8848-8869
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2149949019
- Cited by
- 288
- References
- 211
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.